IDiyas

For the Inventor, By the Inventor

Tsuchiura, Japan

Masahiro Neya

USPTO Granted Patents = 14

Average Co-Inventor Count = 5.7

ph-index = 6

Forward Citations = 196(Granted Patents)


Location History:

  • Tsukuba, JP (1990 - 1993)
  • Tsuchiura, JP (1994 - 2002)
  • Osaka, JP (2005)

Company Filing History:

goldMedal13 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents
silverMedal1 out of 1 
 
Ujisawa Pharmaceutical Co., Ltd.
 patent

Years Active: 1990-2005

Loading Chart...
14 patents (USPTO):Explore Patents
1. 6967197 - Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors (2005-11-22),
2. 6489324 - Piperazine compounds as inhibitors of MMP or TNF (2002-12-03),
3. 6333324 - Piperazine compounds as inhibitors of MMP or TNF (2001-12-25),
4. 6207686 - Endothelin antagonists (2001-03-27),
5. 5888972 - Peptide compounds, their preparation and uses (1999-03-30),
6. 5656604 - Peptide compound and its preparation (1997-08-12),
7. 5538950 - Endothelin antagonists and their preparation (1996-07-23),
8. 5491132 - Amino acid derivatives, a process for the preparation thereof and (1996-02-13),
9. 5430022 - Peptide compound and its preparation (1995-07-04),
10. 5284828 - Peptide compound and its preparation (1994-02-08),
11. 5223489 - Amino acid derivatives, processes for the preparation thereof and (1993-06-29),
12. 5142048 - Intermediate for preparation of amino acid derivatives (1992-08-25),
13. 4963530 - Renin inhibitor peptide compounds, a process for the preparation thereof (1990-10-16),
14. 4921855 - New Histidyl amino acid derivatives, and pharmaceutical composition (1990-05-01),

Title: The Innovative Contributions of Masahiro Neya

Introduction

Masahiro Neya is a prominent inventor based in Tsuchiura, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that serve as inhibitors for matrix metalloproteinases (MMP) and tumor necrosis factor alpha (TNF-α). With a total of 14 patents to his name, Neya's work has had a substantial impact on therapeutic treatments.

Latest Patents

Neya's latest patents include innovative compounds such as thiazepinyl hydroxamic acid derivatives, which are designed to inhibit MMPs. These compounds feature a complex formula that includes various functional groups, making them useful in treating diseases mediated by MMPs or TNF-α. Another notable patent involves piperazine compounds that also act as inhibitors of MMP or TNF-α, showcasing Neya's expertise in creating effective medicinal agents.

Career Highlights

Throughout his career, Masahiro Neya has worked with esteemed organizations such as Fujisawa Pharmaceutical Company, Ltd. and Ujisawa Pharmaceutical Co., Ltd. His experience in these companies has allowed him to refine his skills and contribute to groundbreaking research in pharmaceutical development.

Collaborations

Neya has collaborated with notable colleagues, including Keiji Hemmi and Natsuko Kayakiri. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the quality of his research and inventions.

Conclusion

Masahiro Neya's contributions to the field of medicinal chemistry are noteworthy, with a focus on developing innovative compounds that address critical health issues. His extensive patent portfolio and collaborations reflect his dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…